Brilinta Review Highlights Evidence Gap On Aspirin Dosing

The right aspirin dose is a looming unknown in dual antiplatelet therapy. However, unless the National Institutes of Health or another entity steps in to run a large, expensive study, it appears likely the question will remain unanswered